![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Erem Cihangir
Publisher: Humana Press, Inc
ISSN: 0969-711X
Source: Endocrine Journal, Vol.35, Iss.1, 2009-02, pp. : 75-80
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Thrombin-Activatable Fibrinolysis Inhibitor in Breast Cancer Patients
Medical Principles and Practice, Vol. 20, Iss. 4, 2011-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Endocrine Journal, Vol. 33, Iss. 3, 2008-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Watanabe R. Wada H. Watanabe Y. Sakakura M. Nakasaki T. Mori Y. Nishikawa M. Gabazza E.C. Nobori T. Shiku H.
Thrombosis Research, Vol. 104, Iss. 1, 2001-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Hryszko T. Malyszko J. Malyszko J.S. Brzosko S. Mysliwiec M.
Thrombosis Research, Vol. 104, Iss. 4, 2001-11 ,pp. :